#China #Guangzhou #Cosmetics Research #Yatsen Group #IFSCC Congress

Yatsen Group Sets a New Benchmark at IFSCC Congress

Yatsen Holding Limited, traded on the NYSE under the ticker symbol YSG, recently made an impressive mark at the 36th International Federation of Societies of Cosmetic Chemists (IFSCC) Congress held in Perth, Australia. The renowned beauty group, recognized for its innovative approach in the industry, presented a record-breaking 20 research submissions—almost doubling its contributions compared to the previous year. This milestone participation solidifies Yatsen's continuing commitment to scientific advancement in the cosmetics sector.

Commitment to Research and Innovation

Deng Yi, the Research and Development (R&D) Director at Yatsen, presented significant findings at the event, which highlights Yatsen’s ongoing dedication to cutting-edge research. Yatsen's achievement stems from a highly competitive selection process where its submissions were handpicked from over 1,200 proposals following multiple rounds of expert evaluations. Jing Cheng, Yatsen’s Chief Scientific Officer, emphasized the significance of this accomplishment, stating, “Our contributions across multiple brands showcase the strength of our global research and development ecosystem.”

Diverse Research Areas

The comprehensive studies presented by Yatsen spanned nine critical fields in cosmetics science, including:

1. Advanced scientific mechanisms
2. Active ingredient innovation
3. Efficacy evaluation
4. Skin microbiome
5. Color cosmetic innovations
6. Skin neuroscience
7. Preservative and microbiological science
8. Computational toxicology
9. Formulation delivery system innovations

Among the highlights was a novel testing methodology introduced by Yi Deng, which focuses on minimizing preservative interference and aims to reduce false negatives, thus establishing a more reliable quality assurance standard reflective of real-world production scenarios in cosmetic formulations.

Collaborations and Expansive R&D Network

Yatsen Group’s commitment to research is further demonstrated by its extensive R&D network, which includes advanced manufacturing facilities, three global R&D centers, and numerous joint laboratories and research platforms. Over the years, Yatsen has shown an unwavering investment in R&D, allocating upwards of 770 million RMB to this area. The company has consistently spent more than 3% of its revenue on research over the last four years, signifying a strategic approach towards driving innovation.

As of June 30, 2026, Yatsen had submitted 282 patent applications and had published 55 academic papers, reinforcing its position as a vital player in paving the future of cosmetics.

About Yatsen Group

Founded in 2016, Yatsen Holding Limited has quickly evolved into a major figure within the beauty industry. With brands such as Galénic, DR.WU, Eve Lom, Perfect Diary, and Little Ondine, the company caters to various consumer segments, ranging from mass-market products to upscale, clinical-grade skincare solutions. Yatsen's vision extends beyond the borders of China, aspiring to become a prominent player in global beauty innovation.

For further details about their innovative projects and ongoing commitments to research, you can visit their official website or follow them on LinkedIn.